Population pharmacokinetics of oseltamivir: pediatrics through geriatrics. - Wikidata - awgldk - TriplyDB

Population pharmacokinetics of oseltamivir: pediatrics through geriatrics.

Population pharmacokinetics of oseltamivir: pediatrics through geriatrics.

http://www.wikidata.org/entity/Q37036527

about

Interdisciplinary pharmacometrics linking oseltamivir pharmacology, influenza epidemiology and health economics to inform antiviral use in pandemics.Pharmacokinetic-pharmacodynamic determinants of oseltamivir efficacy using data from phase 2 inoculation studies.Pharmacokinetics and safety of oseltamivir in patients with end-stage renal disease treated with automated peritoneal dialysis Investigating clinically adequate concentrations of oseltamivir carboxylate in end-stage renal disease patients undergoing hemodialysis using a population pharmacokinetic approach.Population pharmacokinetics of oseltamivir in non-pregnant and pregnant women.Population pharmacokinetics of oseltamivir and oseltamivir carboxylate in obese and non-obese volunteers.Pharmacokinetics of MHAA4549A, an Anti-Influenza A Monoclonal Antibody, in Healthy Subjects Challenged with Influenza A Virus in a Phase IIa Randomized Trial.Population pharmacokinetic analysis of oseltamivir and oseltamivir carboxylate following intravenous and oral administration to patients with and without renal impairment.The posology of oseltamivir in infants with influenza infection using a population pharmacokinetic approach.Oseltamivir pharmacokinetics in Mexican obese and non-obese healthy subjects and patients. Evidence for an absence of interethnic variability.

P2860

Q30398368-E7562658-6527-4C27-9AB2-E32209581BEA Q30625335-2BB0EE7F-E031-4378-A13D-3E4C9DD8D9CB Q35286102-E6DC3F63-7652-46A5-AFDF-589BF1610CF2 Q36158241-2A78132F-06E8-4A67-99E5-8D9C89A9F4BA Q36243630-68391E00-23F6-4713-BCB0-11573C2FE711 Q36924693-C6F8B145-9FB7-4153-A923-E54F58DB6594 Q38375170-90598DBF-3E1E-47A6-81DC-19E9769AC57E Q41143036-E1F420A6-AA3D-4ED6-A679-E8E08765558B Q42216493-640BEC39-0553-4991-A92E-60FE26C6FD52 Q42318178-1DBC6EB3-E8B8-48C2-A67F-75A59479A003

P2860

Population pharmacokinetics of oseltamivir: pediatrics through geriatrics.

http://www.wikidata.org/entity/Q37036527

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 13 May 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Population pharmacokinetics of oseltamivir: pediatrics through geriatrics.

@en

Population pharmacokinetics of oseltamivir: pediatrics through geriatrics.

@nl

type

label

Population pharmacokinetics of oseltamivir: pediatrics through geriatrics.

@en

Population pharmacokinetics of oseltamivir: pediatrics through geriatrics.

@nl

prefLabel

Population pharmacokinetics of oseltamivir: pediatrics through geriatrics.

@en

Population pharmacokinetics of oseltamivir: pediatrics through geriatrics.

@nl

P1433

Q37036527-0F35D9CF-2272-4191-A72B-18ACD4091410

P1476

Q37036527-8221D904-4165-45C4-8247-1892CD1FD6AB

P2093

Q37036527-2E6C7BE3-3D1E-4E28-B2E1-707B57535E6B

Q37036527-469D9F64-F3F5-4676-BA91-F243BB3D2610

Q37036527-58D44308-F4F5-453E-B9BC-DCBF82D1D064

Q37036527-644FD5AB-9246-410B-B60B-E9202C6FB2B3

Q37036527-6F07725A-0FAE-43E2-B0E2-94601A0A98C1

Q37036527-7CE051AF-A241-495B-8907-6B6420442ECC

Q37036527-8D08640D-0525-4039-8361-F82F6AFCDE6D

Q37036527-E3B9D9F3-4F23-4EB0-A4D5-E61836B26BEE

Q37036527-F5EBDAE7-9577-4E80-A67B-F94D4D0CC320

Q37036527-F7C73C5D-06AF-4F56-BC2B-181E98C12399

P2860

Q37036527-0F11F699-E048-4451-A43D-21B7495CD01C

Q37036527-1553E154-EA5D-4DCB-8A1C-5AE018DE0B45

Q37036527-1EE8D819-14C6-44C3-8074-897B2FE45A72

Q37036527-218BA267-6D03-4A50-869D-FED5F5C4BBB3

Q37036527-2B7F8829-9D06-4411-8257-096AD63D9CEE

Q37036527-323EEF1F-D64B-4A54-8428-BABB5E0E1249

Q37036527-356437BD-D549-4605-9D65-9898E9FB1C42

Q37036527-3957733A-9C9D-48CA-975F-7912C98D6E7D

Q37036527-3A0663EF-3CC0-4BC9-BEC7-515276880C2A

Q37036527-3EE1A151-096F-498C-BD80-2AEDC037C3C2

P304

Q37036527-05B03588-84D9-439E-8DAA-70060BE532EE

P31

Q37036527-B7306C98-49A7-48DB-844E-04F09EA847E6

Q37036527-b6c32d60-02c4-4d9e-8742-b7adfcaaecde

P356

Q37036527-21048D70-2DE2-4F20-9A1E-6CD5A32734A4

P407

Q37036527-40E95E85-3271-431A-8BB4-632C9D189D67

P433

Q37036527-D13B7625-4525-4BC8-B362-2F8816B7E82D

P478

Q37036527-6EA58C33-8AB9-4728-A5BE-FE97524011B6

P577

Q37036527-4570C118-E01A-4871-985E-2ED83B6F106A

P5875

Q37036527-0884799C-FDD4-4650-9F34-DAA3BCFE3F14

P698

Q37036527-83D36230-5B8F-4236-B35E-58AC1C0B5112

P932

Q37036527-9B9F618A-19C4-49E2-B62F-D0A0FED6D360

P356

P1433

Antimicrobial Agents and Chemotherapy

P1476

Population pharmacokinetics of oseltamivir: pediatrics through geriatrics.

@en

P2093

Alan Forrest

http://www.w3.org/2001/XMLSchema#string

Catharine C Bulik

http://www.w3.org/2001/XMLSchema#string

Craig R Rayner

http://www.w3.org/2001/XMLSchema#string

Daniel K Reynolds

http://www.w3.org/2001/XMLSchema#string

Mohamed A Kamal

http://www.w3.org/2001/XMLSchema#string

Patrick F Smith

http://www.w3.org/2001/XMLSchema#string

Paul G Ambrose

http://www.w3.org/2001/XMLSchema#string

Scott A Van Wart

http://www.w3.org/2001/XMLSchema#string

Sujata M Bhavnani

http://www.w3.org/2001/XMLSchema#string

Vishak Subramoney

http://www.w3.org/2001/XMLSchema#string

P2860

Pharmacokinetics of oseltamivir: an oral antiviral for the treatment and prophylaxis of influenza in diverse populations

New equations to estimate GFR in children with CKD

Prediction of creatinine clearance from serum creatinine

Use of the oral neuraminidase inhibitor oseltamivir in experimental human influenza: randomized controlled trials for prevention and treatment.

Oral oseltamivir in human experimental influenza B infection.

Pharmacologic considerations for oseltamivir disposition: focus on the neonate and young infant.

Oseltamivir and oseltamivir carboxylate pharmacokinetics in obese adults: dose modification for weight is not necessary.

Prediction-corrected visual predictive checks for diagnosing nonlinear mixed-effects models.

Pharmacokinetic-pharmacodynamic determinants of oseltamivir efficacy using data from phase 2 inoculation studies.

Effectiveness of oseltamivir in preventing influenza in household contacts: a randomized controlled trial.

P304

3470-3477

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.02438-12

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

57

http://www.w3.org/2001/XMLSchema#string

P577

2013-05-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

236739295

http://www.w3.org/2001/XMLSchema#string

P698

23669384

http://www.w3.org/2001/XMLSchema#string

P932

3719735

http://www.w3.org/2001/XMLSchema#string